Zhabilov

Helping people fight serious diseases has been the focus of Harry Zhabilov’s adult life. He served for years in a laboratory with his father Dr. Zhabilov Sr., a prominent research scientist at the Bulgarian Academy of Sciences. Harry Zhabilov’s father concentrated on manipulating the immune system to fight HIV/AIDS, and conducted laboratory tests to explore that concept. In addition, Harry Zhabilov Sr. also researched alternative approaches to treating these diseases. Harry Zhabilov and his father were particularly interested in TNP, or thymus nuclear protein. Harry Zhabilov served for several decades with his father and conducted research in the laboratory and on human subjects. Today Harry Zhabilov functions as President, Vice Chairman of the Board, and Chief Science Officer at Immunotech Laboratories, Inc., a Glendale, California, company dedicated to developing a treatment called IPF (irreversible pepsin fraction) for viral and immune diseases. Far more economical to manufacture than prior technologies, IPF proves more effective as well. Harry Zhabilov holds a patent for IPS, which he received in January of 2009. In addition, Harry Zhabilov has applied for several other patents that are currently pending. At Immunotech Laboratories, Harry Zhabilov works among many brilliant scientists. Together the team strives to help Immunotech Laboratories remain a leader in the field of research and development of drugs that treat the immune system. Harry Zhabilov earned a Bachelor of Science and a Master’s degree in Chemistry and Chemical Engineering. Dedicated to fighting infectious diseases, he continues his important work at Immunotech Laboratories with fervor, employing his gifts for social good.